NCT02207699 - Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

Benzonatate 200 mg

2 benzonatate 100 mg perles and 6 placebo perles give by mouth once

DRUG

Benzonatate 800 mg

8 benzonatate 100 mg perles given by mouth once

DRUG

Moxifloxacin 400 mg

1 moxifloxacin 400 mg tablet given by mouth once

DRUG

Placebo

8 placebo perles given by mouth once

Trial Locations (1)

Pfizer Investigational Site, Overland Park